Translational study investigating the role of circulating biomarkers of breast cancer that indicate its potential progression and resistance to therapy.
August 6, 2020
Translational study investigating the role of circulating biomarkers of breast cancer that indicate its potential progression and resistance to therapy.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
